These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38627854)

  • 1. Integration of single-cell RNA-seq and bulk RNA-seq data to construct and validate a cancer-associated fibroblast-related prognostic signature for patients with ovarian cancer.
    Shen L; Li A; Cui J; Liu H; Zhang S
    J Ovarian Res; 2024 Apr; 17(1):82. PubMed ID: 38627854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
    Yu L; Shen N; Shi Y; Shi X; Fu X; Li S; Zhu B; Yu W; Zhang Y
    Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
    Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
    Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts.
    Ren Q; Zhang P; Lin H; Feng Y; Chi H; Zhang X; Xia Z; Cai H; Yu Y
    Front Immunol; 2023; 14():1201573. PubMed ID: 37325647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
    Liu W; Wang M; Wang M; Liu M
    Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
    Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
    J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma.
    Liu Y; Jian J; Zhang Y; Wang L; Liu X; Chen Z
    Front Oncol; 2023; 13():1170893. PubMed ID: 37124542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer.
    Li C; Yang L; Zhang Y; Hou Q; Wang S; Lu S; Tao Y; Hu W; Zhao L
    Front Immunol; 2023; 14():1307588. PubMed ID: 38235137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
    Zheng H; Liu H; Ge Y; Wang X
    Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating single-cell and bulk RNA sequencing to predict prognosis and immunotherapy response in prostate cancer.
    Wen XY; Wang RY; Yu B; Yang Y; Yang J; Zhang HC
    Sci Rep; 2023 Sep; 13(1):15597. PubMed ID: 37730847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation-related genes mediated prognostic signature contribute to prognostic prediction and treatment options in ovarian cancer: based on bulk and single‑cell RNA sequencing data.
    You Y; Yang Q
    BMC Cancer; 2024 Feb; 24(1):207. PubMed ID: 38355446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Cancer-Associated Fibroblast-Related Prognostic Model in Breast Cancer via Bulk and Single-Cell RNA Sequencing.
    Hu J; Jiang Y; Wei Q; Li B; Xu S; Wei G; Li P; Chen W; Lv W; Xiao X; Lu Y; Huang X
    Biomed Res Int; 2022; 2022():2955359. PubMed ID: 36510567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unveils heterogeneity and establishes a novel signature for prognosis and tumor immune microenvironment in ovarian cancer.
    Wang Z; Zhang J; Dai F; Li B; Cheng Y
    J Ovarian Res; 2023 Jan; 16(1):12. PubMed ID: 36642706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model.
    Liang L; Yu J; Li J; Li N; Liu J; Xiu L; Zeng J; Wang T; Wu L
    Front Oncol; 2021; 11():711020. PubMed ID: 34621670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analysis of cancer-associated fibroblast signature in gastric cancer.
    Zhao Z; Mak TK; Shi Y; Li K; Huo M; Zhang C
    Heliyon; 2023 Sep; 9(9):e19217. PubMed ID: 37809716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer-associated fibroblast-related gene signature for predicting survival and therapy in gastric cancer.
    Zhou Z; Guo S; Lai S; Wang T; Du Y; Deng J; Zhang S; Gao G; Zhang J
    BMC Cancer; 2023 Jan; 23(1):108. PubMed ID: 36717783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
    Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.